drugset / Trial / NCT07570940

A Study Of Stellate Ganglion Blockade With Liposomal Bupivacaine In Preventing Atrial Fibrillation After Isolated Coronary Artery Bypass Grafting Surgery

NCT07570940

Phase 4 Not yet recruiting 450 enrolled Mayo Clinic
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is assess the incidence of postoperative atrial fibrillation (POAF) within one week of surgery in patients who receive pre-surgical stellate ganglion blockade with liposomal bupivacaine, compared to those receiving a saline placebo, using continuous electrocardiographic monitoring via wearable ECG devices.

Timeline

Start
2026-06
Primary completion
2030-06
Completion
2030-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Bupivacaine Other / unclassified 133 mg Other